Amicus Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
06.09.24
/
50%
€10.70
Target price
06.09.25
€16.18
Performance (%)
-8.41%
Price
20.09.24
€9.70
Summary
This prediction is currently active. With a performance of -8.41%, the BUY prediction for Amicus Therapeutics Inc. by Jefferies_Financial_ is down slightly. This prediction currently runs until 06.09.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amicus Therapeutics Inc. | -4.902% |
| iShares Core DAX® | 0.347% |
| iShares Nasdaq 100 | 0.715% |
| iShares Nikkei 225® | 1.522% |
| iShares S&P 500 | 0.631% |
Comments by Jefferies_Financial_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $18.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat